Pharming Group N.V. ADS, each representing 10 share price logo

Pharming Group N.V. ADS, each representing 10

NASDAQ: PHAR

Small Cap

$12.98

+0.11

(+0.85%)

as on

Pharming Group N.V. ADS, each representing 10 Stock Performance

as on June 25, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $12.92
    $13.38
    downward going graph

    0.46%

    Downside

    3.08%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $9.54
    $21.34
    downward going graph

    26.54%

    Downside

    64.41%

    Upside

    downward going graph

Pharming Group N.V. ADS, each representing 10 share price movements today

Previous Close
$12.87
Open
$13.03
Volume
112.8K
Day's Low - High
$12.92 - $13.38
52 Week Low - High
$9.54 - $21.34

Pharming Group N.V. ADS, each representing 10 Historical Returns

1 Month Return
+ 3.02 %
3 Month Return
-20.02 %
1 Year Return
+ 20.25 %
3 Year Return
+ 18.12 %
5 Year Return
+ 10.7 %

Pharming Group N.V. ADS, each representing 10 Stock Fundamentals & Key Indicators

Check Pharming Group N.V. ADS, each representing 10 market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$927.4M

EPS (TTM)

0.2303

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.04%

PE Ratio (TTM)

69.11

Industry PE ratio

-3.750247191011236

PEG Ratio

0

EBITDA

42.3M

Revenue (TTM)

369.5M

Profit Margin

3.34%

Return On Equity TTM

5.04%

Pharming Group N.V. ADS, each representing 10 Stock Valuation

Track how Pharming Group N.V. ADS, each representing 10 P/E has moved over time to understand its valuation trends.

Pharming Group N.V. ADS, each representing 10 in the last 5 years

  • Overview

  • Trends

Lowest (-179.29x)

March 31, 2025

Industry (-3.75x)

June 25, 2026

Today (69.11x)

June 25, 2026

Highest (154.11x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: 69.11x

Pharming Group N.V. ADS, each representing 10 vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pharming Group N.V. ADS, each representing 10 with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Pharming Group N.V. ADS, each representing 10 image
Pharming Group N.V. ADS, each representing 10
BUY$927.4M10.7%69.113.34%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$38.5B67.66%72.4112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$118.9B144.52%27.7835.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$64.8B13.24%15.0829.65%0.58%

Stock Returns calculator for Pharming Group N.V. ADS, each representing 10 Stock including INR - Dollar returns

The Pharming Group N.V. ADS, each representing 10 stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pharming Group N.V. ADS, each representing 10 investment value today

Current value as on today

₹1,32,504

Returns

₹32,504

(+32.5%)

Returns from Pharming Group N.V. ADS, each representing 10 Stock

₹20,297 (+20.3%)

Dollar Impact

₹12,208 (+12.21%)

Analyst Recommendation on Pharming Group N.V. ADS, each representing 10 Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Pharming Group N.V. ADS, each representing 10. Average target price of $34.35

Pharming Group N.V. ADS, each representing 10 Share Price Target

Get share price movements and forecasts by analysts on Pharming Group N.V. ADS, each representing 10.

What analysts predicted

62.21%UPSIDE

Target Price

$34.35

Current Price

$12.98

Analyzed by

14 Analysts

Target

$34.35

Pharming Group N.V. ADS, each representing 10 target price $34.35, a slight upside of 62.21% compared to current price of $12.98. According to 14 analysts rating.

Indian Investors' Interest in Pharming Group N.V. ADS, each representing 10 Stock

Search interest for Pharming Group N.V. ADS, each representing 10 Stock has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:26% versus previous 30 day period

Pharming Group N.V. ADS, each representing 10 Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
81
55
74
74
92,700
79
93
97
106
72
Gross Profit
74
47
66
68
80,500
70
84
90
82
65
Operating Income
0
-16
-3
4
6,600
-7
10
15
1
-5
EBITDA
8
-9
2
7
-
-4
9
23
5
1
Interest Expense
4
1
1
2
-
5
0
7
2
2
Depreciation
7
5
0
2
7
2
2
2
3
3
Income Before Tax
-2
-16
0
1
6,700
-11
7
12
4
-4
Income Tax Expense
0
-4
1
2
-
3
2
5
0
0
Net Income
-2
-12
-1
-1
2,900
-14
4
7
5
-5
Net Profit Margin
-3.33%
-22.39%
-1.62%
-1.38%
3.13%
-18.61%
5.04%
7.76%
4.98%
-7.20%

Pharming Group N.V. ADS, each representing 10 Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
16
89
154
189
212
225
205
245
307
377
Gross Profit
11
92
129
165
188
201
188
220
271
331
Operating Income
-12
21
43
68
76
15
18
-5
-8
20
EBITDA
-13
25
41
71
58
55
33
9
16
31
Interest Expense
6
45
16
13
10
7
5
5
9
21
Depreciation
-
3
6
5
7
16
13
15
16
11
Income Before Tax
-18
-85
0
52
44
26
14
-12
-8
12
Income Tax Expense
3
-11
24
11
6
8
1
-1
3
10
Net Income
-18
-73
28
40
37
18
13
-10
-12
2
Net Profit Margin
-110.48%
-81.99%
18.50%
21.41%
17.79%
8.04%
6.65%
-4.30%
-3.98%
0.76%

Pharming Group N.V. ADS, each representing 10 Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-16
-1
-1
3
-11
7
7
5
-5
Operating Cash Flow
-7
-13
9
9
0
11
30
7
1
Investing Cash Flow
0
36
4
-
9
16
-2
0
-85
Financing Cash Flow
-2
-28
-1
-2
-6
-2
11
3
-9
Change in Cash
-9
-4
13
-2
5
31
38
13
-92

Pharming Group N.V. ADS, each representing 10 Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
26
43
52
44
26
14
-12
-8
2
Operating Cash Flow
45
46
74
83
42
22
-17
-1
50
Investing Cash Flow
-7
-4
-28
-15
-24
5
-129
32
18
Financing Cash Flow
-3
-20
-63
60
-31
-4
-1
-35
14
Change in Cash
33
24
-17
130
-15
15
-145
-7
91

Global Institutional Holdings in Pharming Group N.V. ADS, each representing 10

Funds
Holdings
UBS Group AG
0%
Morgan Stanley - Brokerage Accounts
0.02%
Coldstream Capital Management Inc
0%
Citadel Advisors Llc
0.01%
Stone House Investment Management, LLC
0%
See all

Insights on Pharming Group N.V. ADS, each representing 10

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PHAR has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PHAR has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 106.42M → 72.44M (in $), with an average decrease of 31.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, PHAR stock has moved down by -20.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 7.54M → -5.21M (in $), with an average decrease of 114.1% per quarter

About Pharming Group N.V. ADS, each representing 10

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K" inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
OrganisationPharming Group N.V. ADS, each representing 10
HeadquartersDarwinweg 24, Leiden, Netherlands, 2333 CR
IndustryBiotechnology
CEOMr. Fabrice Chouraqui M.B.A., Ph.D., Pharm.D.
E-voting on sharesClick here to vote

Key Management of Pharming Group N.V. ADS, each representing 10

Name

Title

Mr. Kenneth Lynard EMBA, M.Sc.

Chief Financial Officer

Mr. Michael K. Levitan

VP of Investor Relations & Corporate Communications

Mr. Ruud Van Outersterp L.L.M.

Chief Legal & Compliance Officer and Company Secretary

Ms. Ines Bernal

Chief People Officer

Dr. Alexander Breidenbach M.B.A., Ph.D.

Chief Business Officer

Mr. Fabrice Chouraqui M.B.A., Ph.D., Pharm.D.

CEO & Executive Director

Ms. Mireille Sanders M.Sc.

Chief Operations Officer

Dr. Anurag Relan M.D., MPH

Chief Medical Officer

Ms. Leverne Marsh BPHARM

Chief Commercial Officer

Dr. Magnus Hansson

Medical Director

FAQs

What is Pharming Group N.V. ADS, each representing 10 share price today?

Pharming Group N.V. ADS, each representing 10 share price today is $12.98 as on at the close of the market. Pharming Group N.V. ADS, each representing 10 share today touched a day high of $13.38 and a low of $12.92.

What is the 52 week high and 52 week low for Pharming Group N.V. ADS, each representing 10 share?

Pharming Group N.V. ADS, each representing 10 share touched a 52 week high of $21.34 on and a 52 week low of $9.54 on . Pharming Group N.V. ADS, each representing 10 stock price today i.e. is closed at $12.98,which is 39.18% down from its 52 week high and 36.12% up from its 52 week low.

What is Pharming Group N.V. ADS, each representing 10's market capitalisation today?

Pharming Group N.V. ADS, each representing 10 market capitalisation is $0.00T as on .

How to invest in Pharming Group N.V. ADS, each representing 10 Stock (PHAR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pharming Group N.V. ADS, each representing 10 on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pharming Group N.V. ADS, each representing 10 Shares that will get you 0.1156 shares as per Pharming Group N.V. ADS, each representing 10 share price of $12.98 per share as on June 25, 2026 at 8:46 am IST.

What is the minimum amount required to buy Pharming Group N.V. ADS, each representing 10 Stock (PHAR) from India?

Indian investors can start investing in Pharming Group N.V. ADS, each representing 10 (PHAR) shares with as little as ₹94.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.65 in Pharming Group N.V. ADS, each representing 10 stock (as per the Rupee-Dollar exchange rate as on ). Based on Pharming Group N.V. ADS, each representing 10 share’s latest price of $12.98 as on June 25, 2026 at 8:46 am IST, you will get 0.7704 shares of Pharming Group N.V. ADS, each representing 10. Learn more about fractional shares .

What are the returns that Pharming Group N.V. ADS, each representing 10 has given to Indian investors in the last 5 years?

Pharming Group N.V. ADS, each representing 10 stock has given 10.7% share price returns and 27.62% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?